While the virus has the potential to infect humans, no real-world cases have been identified, and it does not enter human ...

Our latest posters, at the world's most prestigious gene therapy event, provide critical insights into the safety and efficacy of rAAV-based therapeutics. We support biopharma companies with ...

First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...